Tesfaye S, Boulton AJM, Dyck PJ, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity and treatments. Diabetes Care. 2010;33:2285–93.PubMedCrossRef

Watkins PJ, Edmonds ME. Clinical features of diabetic neuropathy. In: Pickup J, Williams G, editors. Textbook of diabetes, vol. 2. Oxford: Blackwell Science; 1997. p. 50.1–50.20.

Andersen H. Motor dysfunction in diabetes. Diabetes Metab Res Rev. 2012;28 Suppl 1:89–92.PubMedCrossRef

Watkins PJ. Pain and diabetic neuropathy. Br Med J. 1984;288:168–9.CrossRef

Tesfaye S, Vileikyte L, Rayman G, et al. on behalf of the Toronto Expert Panel on Diabetic Neuropathy*. Painful diabetic peripheral neuropathy: Consensus recommendations on diagnosis, assessment and management. Diabetes Metab Res Rev. 2011;27:629–38.

Tölle T, Xu X, Sadosky AB. Painful diabetic neuropathy: a cross-sectional survey of health state impairment and treatment patterns. J Diabetes Complications. 2006;20(1):26–33.PubMedCrossRef

Gore M, Brandenburg NA, Dukes E, et al. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptom Manage. 2005;30:374–85.PubMedCrossRef

Vileikyte L, Leventhal H, Gonzalez J, et al. Diabetic peripheral neuropathy and depressive symptoms: the association revisited. Diabetes Care. 2005;28:2378–83.PubMedCrossRef

Vileikyte L, Peyrot M, Gonzalez JS, et al. Predictors of depressive symptoms in persons with diabetic peripheral neuropathy: a longitudinal study. Diabetologia. 2009;52:1265–73.PubMedCrossRef

Boulton AJ. What you can’t feel can hurt you. J Am Podiatr Med Assoc. 2010;100(5):349–52.PubMed

Ward JD. The diabetic leg. Diabetologia. 1982;22:141–7.PubMedCrossRef

Tesfaye S. Diabetic neuropathy: achieving best practice. Br J Vasc Dis. 2003;3:112–7.CrossRef

Boulton AJ. Diabetic foot—what can we learn from leprosy? Legacy of Dr Paul W. Brand. Diabetes Metab Res Rev. 2012;28 Suppl 1:3–7.PubMedCrossRef

Ward JD, Simms JM, Knight G, Boulton AJM, Sandler DA. Venous distension in the diabetic neuropathic foot (physical sign of arterio-venous shunting). J R Soc Med. 1983;76:1011–4.PubMed

Boulton AJM, Scarpello JHB, Ward JD. Venous oxygenation in the diabetic neuropathic foot: evidence of arterial venous shunting? Diabetologia. 1982;22:6–8.PubMedCrossRef

Edmonds ME, Archer AG, Watkins PJ. Ephedrine: a new treatment for diabetic neuropathic oedema. Lancet. 1983;1:548–51.PubMedCrossRef

Tesfaye S, Stephens L, Stephenson J, Fuller J, Platter ME, Ionescu-Tirgoviste C, Ward JD. The prevalence of diabetic neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia. 1996;39:1377–84.PubMedCrossRef

Tesfaye S, Chaturvedi N, Eaton SEM, Witte D, Ward JD, Fuller J. Vascular risk factors and diabetic neuropathy. N Engl J Med. 2005;352:341–50.PubMedCrossRef

Shaw JE, Zimmet PZ, Gries FA, Ziegler D. Epidemiology of diabetic neuropathy. In: Gries FA, Cameron NE, Low PA, Ziegler D, editors. Textbook of diabetic neuropathy. Stuttgart: Thieme; 2003. p. 64–82.

Daousi C, McFarlane IA, Woodward A, Nurmikko TJ, Bendred PE, Benbow SJ. Chronic painful peripheral neuropathy in an urban community: a control comparison of people with and without diabetes. Diabet Med. 2004;21:976–82.PubMedCrossRef